easy weight loss, easy weight lose, easyweightlose.com , easy weight loss, free weight loss easy weight loss, easy weight lose, easyweightlose.com , easy weight loss, free weight loss

20Feb/100

Rituxan Approved for Chronic Lymphocytic Leukemia (HealthDay)

HealthDay - FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been
approved by the U.S. Food and Drug Administration to treat a slowly
progressing form of blood and bone marrow cancer known as chronic
lymphocytic leukemia (CLL), the agency said in a press release.

Comments (0) Trackbacks (0)

No comments yet.


Leave a comment

(required)

Trackbacks are disabled.